Valuation
- Market cap
- 1,280,841,000
- Revenue TTM
- $780,990,000
- Net income TTM
- $39,580,000
- P/E (trailing)
- 34.08
- P/E (forward)
- 29.98
- Profit margin
- 5.07%
- Debt to equity
- 0.48
Trading
- Volume
- 191,153
- Avg volume
- 171,244
- Day's range
- $84.62 – $86.60
- Shares out
- 14,923,000
- Stochastic %K
- 50%
- Beta
- 1.12
- Analysts
- Strong Buy
- Price target
- $97.83
Company profile
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-rel...
Show more
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.
- Industry
- Medical Care Facilities
- Sector
- Healthcare
- Phone
- 713 297 7000
- Website
- https://www.usph.com
- Address
- 1300 West Sam Houston Parkway South, Suite 300, Houston, United States
Latest news
No headlines yet.
Stocktwits
Estimize
Aug 12, 8:00 PM
Wall St is expecting 0.77 EPS for
$USPH Q3 [Reporting 11/10 AMC]
http://www.estimize.com/intro/usph?chart=historical&metric_name=eps&utm_co
IN0V8
Aug 10, 6:41 PM
$USPH Buying Opportunity
Barrington Research raises target price to
$98 from
$90
0 replies
StocktwitsEarnings
Aug 6, 12:30 PM
$USPH Q2 '26 Earnings Results & Recap
U.S. Physical Therapy, Inc. reaffirmed its full year 2026 adjusted EBITDA guidance, projecting a range of
$102.0 million to
$106.0 million for the total fiscal year period.
0 replies
kikiatwork
May 13, 1:30 PM
$USPH Now we're at a PE of 122 with declining earnings. Great job. Large corporate PT businesses are circling the drain. Margin erosion.
0 replies
StocktwitsEarnings
May 6, 8:40 PM
$USPH Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of -
$0.12 down -115.00% YoY
• Reported revenue of
$198.29M up 7.89% YoY
• U.S. Physical Therapy reaffirmed full year 2026 adjusted EBITDA guidance of
$102M to
$106M, incorporating two hospital affiliations and the January 1, 2026 Medicare rate increase.
0 replies
